2014 – present |
Director and Tenured Professor; AIDS Institute, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR |
| |
2007 – 2014 |
Director and Tenure-track Associate Professor; AIDS Institute, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR |
| |
2002 – 2007 |
Guest Professor and Ph.D. Advisor, State Key Laboratory of Virology of China, Modern Virology Research Center and AIDS Center, College of Life Sciences, Wuhan University, China |
| |
2002 – 2007 |
Staff Investigator and Assistant Professor, Aaron Diamond AIDS Research Center, The Rockefeller University, New York, USA |
| |
1999 – 2002 | Research Scientist, Aaron Diamond AIDS Research Center, The Rockefeller University, New York, USA (Mentor: Professor David D. Ho) |
| |
1996 – 1999 | Postdoctoral Fellow, Aaron Diamond AIDS Research Center, The Rockefeller University, New York, USA (Mentor: Professor David D. Ho) |
| |
Honours/Awards/other Esteemed Factors
1. Charles H. Revson/Norman and Rosita Winston Fellow 1998
2. US NIH F32 Fellow 1998-2002
3. Clinical Infectious Diseases Award for Outstanding Review 2010
4. JAIDS Outstanding Reviewer Award 2015
5. China New Development Award 2019 (Springer Nature)
6. Faculty Knowledge Exchange Award 2018-19 (HKUMed)
7. Knowledge Exchange Excellence Award 2019 (HKU)
8. Outstanding Researcher Award 2020-21 (HKU)
9. Outstanding Research Student Supervisor Award 2020-21 (HKU)
10. Gold Medal in Inventions Geneva Evaluation 2021
11. Faculty Outstanding Research Output Award 2021 (HKUMed)
12. Most Picked Award - 2021 Chinese Scientists with Cell Press (Cell Press)
13. Bronze Medal in Inventions Geneva Evaluation 2022
14. Faculty Outstanding Research Output Award 2022 (HKUMed)
15. Ranked by Clarivate Analytics as the top 1% worldwide by citations and one of the 38 HKU academics among Highly Cited Researchers 2022
Academic Editor and Editorial Board Member
1. Immunotherapy Advances, Founding Editorial Board Member, since 2020; Publisher: Oxford University Press, invited by British Society for Immunology
2. AIDS: Member of Editorial Board, since Jan 2017; Publisher: Lippincott Williams & Wilkins, USA
3. Journal of Acquired Immune Deficiency Syndromes (JAIDS); Member of Editorial Board, since Jan 2010; Publisher: Lippincott Williams & Wilkins, USA
4. Journal of Neuroimmune Pharmacology (JNIP); the peer-reviewed journal of the Society on NeuroImmune Pharmacology. Publisher: Springer
5. Journal of Leukocyte Biology, Guest editor, 2020
6. Current Opinion in HIV and AIDS, Invited guest editor for the November Issue 2020 on COVID-19, together with the invited Editorial Introduction.
7. Journal of Medical Primatology, Member of Editorial Board, since 2008; Publisher: Blackwell-Wiley InterScience
8. PLoS ONE, Academic Editor and Member of Editorial Board since 2010; Publisher: Public Library of Science, USA
9. Journal of Antivirals and Antiretrovirals (Editor/Member of Editorial Board, since 2009); Publisher: OMICS Publishing Group
10. Faculty Member of F1000, F1000 Faculty comprises the world’s leading researchers across all of biology and medicine
Organizing or Scientific Committee for International Conferences on HIV/AIDS
1. 2014 Scientific Committee Member, 20th International AIDS Conference, Melbourne, by International AIDS Society
2. 2015 Scientific Advisory Board, Cent Gardes Conference: HIV Vaccines, France
3. 2016 Scientific Committee Member, Asia-pacific AIDS & Co-Infection Conference
4. 2017 Scientific Committee Member, Asia-pacific AIDS & Co-Infection Conference
5. 2018 Section chair at The HIV Research for Prevention (HIVR4P) international conference in Madrid
6. 2018 Scientific Committee Member, Asia-pacific AIDS & Co-Infection Conference
7. 2019 Invited Speaker, Cent Gardes Conference: HIV Vaccines, France
8. 2020 Invited plenary speaker at the Asia-Pacific AIDS & Co-Infections Conference 2020 in Thailand
9. 2020 Scientific Committee Member, Asia-pacific AIDS & Co-Infection Conference
10. 2020 Section Chair and Plenary Speaker, 5th International Conference & Expo on HIV & AIDS, the HIV-AIDS Summit 2020, Philadelphia, USA
11. 2022 Scientific Committee Member, Asia-pacific AIDS & Co-Infection Conference
12. IAS 2023: World’s largest scientific conference on HIV (Brisbane) by International AIDS Society, Abstract Selection Panel
Scientific Committee for National Academic Conference on HIV/AIDS in China
2015-2022 National Academic Conference on HIV/AIDS, vice-chair for the academic committee for this largest annual conference on HIV/AIDS in China
Reviewer for domestic and international grant applications
1. Hong Kong Health and Medical Fund (HMRF)
2. National Natural Science Foundation of China
3. Science, Technology and Innovation Commission of Shenzhen Municipality
4. American Foundation for AIDS Research (amFAR)
5. The Bill & Melinda Gates Foundation
6. Netherlands Organization for Scientific Research
7. British St Stephen’s AIDS Trust
8. Israel Science Foundation (ISF)
Professional Services at HKU and Local Community
1. |
Director, AIDS Institute, Li Ka Shing Faculty of Medicine, The University of Hong Kong; July 2007 – present |
| |
2. |
Council member, Hong Kong Society for Immunology; Term: 2015 – present |
| |
3. |
Chairman, Hong Kong Society for Immunology; Term: 2018 – 2020 |
| |
4. |
Member, Faculty BBMS Organizing Committee and Curriculum Committee; Term: 2015 – 2020 |
| |
5. |
Member, Faculty High Degree Committee; Term: 2016 – 2019 |
| |
6. |
Member, Advisory Council on AIDS, Department of Health, HKSAR; Term: 2008 – 2014 |
| |
7. |
Board Director, Friends of Hope Education Fund, Hong Kong SAR; Term: 2008 – 2019; Initiated the AIDS orphan educational program, honorary board member |
| |
8. |
Board Director, AIDS Concern, Hong Kong SAR; Term: 2013 – 2016 |
| |
9. |
Board Director, Hong Kong AIDS Foundation, Hong Kong SAR; Term: 2019 – present; to promote HIV education and preventions programs |
| |
The American Society and Association Membership
1. The American Society for Microbiology
2. The American Association of Immunologists
3. American Society on NeuroImmune Pharmacology
4. International AIDS Society
Reviewer for peer-reviewed international journals
AIDS, JAIDS, Immunity, Science Translational Medicine, Journal of Virology, Journal of Clinical Investigation, Journal of Experimental Medicine, Emerging Microbes & Infections, Virology, Clinical Infectious Diseases, Journal of Infectious Diseases, Clinical Chemistry,
Journal of Virological Methods, PLoS One, Journal of Immunology, Applied Microbiology and Biotechnology, Viruses, etc.
Fellowship, Awards and Grants in the USA
1998-1999 |
Fellowship award from the Charles H. Revson/Norman and Rosita Winston Foundation, The Rockefeller University. Role: Principal Investigator |
| |
1998-2002 |
Grant funded by National Institutes of Health (NIH/NIAID, 1F32AI 10256), Characterization of a CCR2-tropic recombinant simian immunodeficiency virus; Role: Principal Investigator |
| |
2000-2001 |
Grant funded by the American Foundation for AIDS Research (amFAR, 02663-27-RGM); Development of a Novel SHIV/Macaque Model for Microbicide Testing, US$120,000; Role: Principal Investigator |
| |
2005-2009 |
Grant from National Institutes of Health, USA; (NIH RO1 HL080211-01); US$2.4 million; A Novel Model for the Study of Lung Pathogenesis of SARS; Role: Principal Investigator |
| |
External Grants Received from the USA for Research at HKU (HK$7.3 million to my group at HKU)
2007-2009 |
Grant from National Institutes of Health, USA; (NIH 5 R01 HL080211-03); US$2.4 million; A Novel Model for the Study of Lung Pathogenesis of SARS; Role: Principal Investigator; (US$292,450 to my HKU Lab) |
| |
2007-2011 |
Grant from National Institutes of Health, USA; (NIH 3 R01 DA020419-02S1); Cannabinoid effects on HIV/AIDS; US$320,000, Role: Co-Principal Investigator |
| |
2008-2009 |
Grant BMGF 52117, Bill & Melinda Gates Foundation; Preventing HIV-1 infection using a novel vaccine immunogen; US$100,000; Role: Principal Investigator |
| |
2017-2021 |
Grant from Bill & Melinda Gates Foundation for the National Institutes of Health (AR170035), USA; Structure-Based Vaccine Design against HIV-1, US$220,000; Role: Co-Principal Investigator |
| |
External Grant Received from the UK for Research at HKU (HK$3.18 million to my group at HKU)
2020-2022 |
Grant from Wellcome Trust (the Funder) for project entitled "A comprehensive study of immunopathogenesis of SARS-CoV-2 infection", £315,689.63 to my group at HKU, Role: Co-Principal Investigator |
External Grant Received from the Coalition for Epidemic Preparedness Innovations (CEPI) for COVID-19 Vaccine Research at HKU (HK$48.36 million)
2020-2020 Phase I US$600,000, Role: Co-Principal Investigator
2020-2022 Phase II US$5,600,000, Role: Co-Principal Investigator
External Awards and Grants Received from Australia for Research at HKU (HK$590300 to my group)
2020-2022 |
Grant from Australian MRFF 2020 COVID-19 Vaccine Candidate Grant Opportunity for project entitled “A safe, effective, and rapidly tuneable SARS-CoV-2 vaccine”, A$100K. Role: Co-Investigator |
External Awards and Grants Received in Hong Kong as PI (HK$110 million to my group)
2008-2009 |
Grant RGC-GRF 762208M, HKSAR; Mucosal vaccine against HIV-1 infection; HK$517,190; Role: Principal Investigator |
| |
2008-2009 |
Understanding the Ongoing HIV Epidemic in Yunnan China; Supported by China AIDS Initiative (Hong Kong Committee); HK$196,000; Role: Principal Investigator |
| |
2009-2012 |
Grant RGC-GRF 762209M, HKSAR; Role of the PD-1/PD-L pathway in AIDS vaccine design; HK$944,700; Role: Principal Investigator |
| |
2010-2012 |
Grant RFCID 09080772, HKSAR; Characterization of novel anti-HIV/TB natural product analogues, HK$800,000; Role: Principal Investigator |
| |
2011-2013 |
AIDS Trust Fund (ATF) MSS 183 R, HKSAR; Establishment of a rapid, high-throughput, cost-effective HIV-1 drug resistance testing system; HK$1,573,000; Role: Principal Investigator |
| |
2011-2013 |
Pneumoconiosis Compensation Fund Board (PCFB), HKSAR; A Novel Vaccine for Mesothelioma Immunotherapy and Prevention; HK$1,718,000; Role: Principal Investigator |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |